Core Viewpoint - The article discusses the performance of non-debt private equity products in the A-share market, highlighting those that have achieved consecutive positive returns over the years, indicating the fund managers' ability to navigate market fluctuations [2][10]. Summary by Sections 2023 Performance - In 2023, among private equity companies managing over 500 million, there were 1,731 non-debt private equity products, with 1,026 (59.27%) achieving consecutive positive returns [2]. - The threshold for the top 20 products in cumulative returns for 2023 was set at ***% [2]. - The majority of the top 20 products (15) were subjective long strategies, with only one product from a billion-dollar private equity firm, Oriental Harbor [2]. Top Products in 2023 - The top five products based on returns were managed by: - Qian Jun from Chiying Private Equity - Zhou Yifeng from Beiheng Fund - Chen Yongbao from Ding Tai Si Fang (Shenzhen) - Wu Gengxin from Zhun Jin Investment - Shi Hao from Shanghai Ge Ru Private Equity [3]. 2021 Performance - For the period from 2021, there were 855 non-debt private equity products, with 184 (21.52%) achieving consecutive positive returns [10]. - The threshold for the top 20 products in cumulative returns for 2021 was also set at ***% [10]. - Half of the top 20 products were subjective long strategies, with a notable presence of quantitative long products [10]. Top Products in 2021 - The top five products were managed by: - He Wenling from Qianhai Guoen Capital - Liu Zhiyong from Caoben Investment - Li Ting from Gongqingcheng Guangju Xinghe Private Equity - Ma Changhai from Hengbang Zhaofeng - Li Jiabin from Qianhai Haifu Asset [11]. 2019 Performance - In 2019, there were 377 non-debt private equity products, with 54 (14.32%) achieving consecutive positive returns [15]. - The threshold for the top 20 products in cumulative returns for 2019 was set at ***% [15]. - The top 20 products included seven subjective long products, with a mix of quantitative long, macro strategies, and composite strategies [15]. Top Products in 2019 - The top five products were managed by: - Yang Zhongxian from Jilu Asset - Chen Yu from Shennong Investment - Yao Qicong from Jiukun Investment - Liang Wentao from Honghu Private Equity - Yu Zilong from Shanghai Yuanlai Private Equity [16][22].

Company Overview - Shennong Investment was established in 2009 and is a pioneer of the "Premium Investment" concept in China's private equity sector, focusing on value growth stocks with a core philosophy of "following the heroes of the era" [3][4] - As of October 2025, the company manages assets worth 3 billion yuan and has received numerous awards, including 11 Private Equity Golden Bull Awards and 9 Yinghua Awards [4][3] - Shennong Investment has consistently achieved positive returns, ranking first among private equity firms with an average return of ***% in 2023 [4][8] Research Team and Key Personnel - The investment research team is composed of elite members from prestigious institutions such as Peking University and Tsinghua University, utilizing standardized processes to enhance decision-making efficiency [6] Investment Philosophy and System - The core investment philosophy is "Premium Investment," focusing on identifying companies with "heroic" characteristics that can significantly impact China through in-depth research and long-term follow-up [10] - The "Premium Stock Selection" system targets high-growth companies in key sectors such as technology, pharmaceuticals, and consumer goods, emphasizing companies with a market size exceeding 100 billion yuan and a potential for tenfold growth over ten years [11] - The "Five-Dimensional Timing" framework evaluates market drivers including policy, economy, capital, valuation, and technical aspects to assess market phases and risk-return changes [12] Investment Process and Risk Control - The investment process follows a scientific management principle, with a structured approach to research that includes daily reports, weekly reports, and in-depth analyses to identify significant investment opportunities [14] - The risk control system involves preemptive warnings for systemic risks, strict stock selection criteria, and ongoing monitoring of portfolio performance [15] Investment Case Studies - In 2020, Shennong Investment identified a leading automotive stock during a market rebound, achieving a price increase of up to six times [17] - In 2022, the firm pivoted to an online retail company, recognizing its undervaluation and resulting in an 18-fold increase in stock price [18] - In 2023, the firm invested in a leading biopharmaceutical company, capitalizing on the anticipated growth in China's biopharmaceutical sector [19] Competitive Advantages - Shennong Investment has demonstrated strong performance through various market cycles, achieving significant returns in bull markets and managing risks effectively in bear markets [22] - The unique "Premium Investment System" combines stock selection and market timing, validated through years of practical experience [23] - The firm is currently in a "sweet spot" for strategy capacity, allowing for flexible investment approaches and continued growth potential [24] - The elite research team ensures high-quality analysis and the ability to uncover investment opportunities [25] Market Outlook - The current market is viewed as being in the "midpoint of a bull market," with expectations of continued upward movement despite volatility [27] - Structural opportunities exist in future-oriented industries, including manufacturing, new consumption, and innovative pharmaceuticals, which align with Shennong Investment's focus [28] - Three major investment trends are anticipated over the next decade: the smart technology wave, the health and wellness wave, and the new consumption wave, driven by changing demographics and consumer preferences [29][30][31]